NCT05228522

Brief Summary

Purpose: This study will test the efficacy of a family-focused lifestyle intervention for reducing type 2 diabetes (T2D) risk factors and increasing Quality of Life (QoL) among high-risk Latino families.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
132

participants targeted

Target at P50-P75 for not_applicable type-2-diabetes

Timeline
2mo left

Started Dec 2021

Longer than P75 for not_applicable type-2-diabetes

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress95%
Dec 2021Jul 2026

Study Start

First participant enrolled

December 12, 2021

Completed
24 days until next milestone

First Submitted

Initial submission to the registry

January 5, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

February 8, 2022

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2026

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 31, 2026

Expected
Last Updated

April 27, 2026

Status Verified

February 1, 2026

Enrollment Period

4.1 years

First QC Date

January 5, 2022

Last Update Submit

April 24, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Glucose Tolerance

    Glucose tolerance will be determined using a standard 75-gram Oral Glucose Tolerance Test (OGTT) with samples collected at fasting and 120 minutes for assessment of glucose concentrations. We will follow the OGTT protocol used by the CDC for the NHANES. Centers for Disease Control. Oral Glucose Tolerance Test (OGTT) Procedures Manual. In: Survey NHaNE, ed2007.

    16 weeks

Secondary Outcomes (6)

  • Weight Specific Quality of Life (QoL)

    16 weeks

  • Total body composition-muscle

    16 weeks

  • Total body composition-fat

    16 weeks

  • Total body composition-bone

    16 weeks

  • Physical Activity

    16 weeks

  • +1 more secondary outcomes

Study Arms (2)

Lifestyle Intervention

EXPERIMENTAL

16-week family-focused intervention that includes nutrition education, behavioral change skills training, and physical activity.

Behavioral: Lifestyle Intervention

Comparison control

NO INTERVENTION

Comparison control families meet with the Study Physician and a Registered Dietitian as a family to review laboratory results and receive lifestyle counseling. Control families will be contacted on a monthly basis for a total of 12 months.

Interventions

16-week family-focused intervention that includes nutrition education, behavioral change skills training, and physical activity.

Lifestyle Intervention

Eligibility Criteria

Age10 Years - 99 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may not qualify if:

  • Latino: self-report
  • Age: 10-16 years
  • Obesity: BMI ≥ 95th percentile for age and sex
  • Type 2 diabetes: (standard American Diabetes Association criteria)
  • Taking medication(s) or diagnosed with a condition that influences carbohydrate metabolism, physical activity, and/or cognition
  • Currently enrolled in (or within previous 12 months) a formal diabetes prevention or weight loss program
  • Self-identify as American Indian
  • Unstable depression or other mental health condition that may impact QoL
  • Currently enrolled in (or within previous 12 months) a formal diabetes prevention or weight loss program
  • Self-identify as American Indian

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Arizona State University

Phoenix, Arizona, 85004, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus, Type 2ObesityPediatric Obesity

Condition Hierarchy (Ancestors)

Diabetes MellitusGlucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System DiseasesOverweightOvernutritionNutrition DisordersBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 5, 2022

First Posted

February 8, 2022

Study Start

December 12, 2021

Primary Completion

January 31, 2026

Study Completion (Estimated)

July 31, 2026

Last Updated

April 27, 2026

Record last verified: 2026-02

Data Sharing

IPD Sharing
Will not share

We will share aggregate data but no individual participant data will be shared with other researchers.

Locations